BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 26700156)

  • 21. High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents.
    Ramalho J; Castillo M; AlObaidy M; Nunes RH; Ramalho M; Dale BM; Semelka RC
    Radiology; 2015 Sep; 276(3):836-44. PubMed ID: 26079490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal Changes in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Magnetic Resonance Images After Intrathecal Administration of Macrocyclic Gadolinium Contrast Agent.
    Ozturk K; Nas OF; Soylu E; Hakyemez B
    Invest Radiol; 2018 Sep; 53(9):535-540. PubMed ID: 29727401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No Signal Intensity Increase in the Dentate Nucleus on Unenhanced T1-weighted MR Images after More than 20 Serial Injections of Macrocyclic Gadolinium-based Contrast Agents.
    Radbruch A; Haase R; Kieslich PJ; Weberling LD; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
    Radiology; 2017 Mar; 282(3):699-707. PubMed ID: 27925871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of at Least 10 Serial Gadobutrol Administrations on Brain Signal Intensity Ratios on T1-Weighted MRI in Children: A Matched Case-Control Study.
    Ozturk K; Nascene D
    AJR Am J Roentgenol; 2021 Sep; 217(3):753-760. PubMed ID: 33112200
    [No Abstract]   [Full Text] [Related]  

  • 25. Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: an intraindividual comparative study.
    Conte G; Preda L; Cocorocchio E; Raimondi S; Giannitto C; Minotti M; De Piano F; Petralia G; Ferrucci PF; Bellomi M
    Eur Radiol; 2017 Oct; 27(10):4372-4378. PubMed ID: 28357495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images: Evaluation of the Macrocyclic Gadolinium-Based Contrast Agent Gadobutrol.
    Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
    Invest Radiol; 2015 Dec; 50(12):805-10. PubMed ID: 26523910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.
    Ramalho J; Semelka RC; AlObaidy M; Ramalho M; Nunes RH; Castillo M
    Eur Radiol; 2016 Nov; 26(11):4080-4088. PubMed ID: 26911888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weekly enhanced T1-weighted MRI with Gadobutrol injections in MS patients: Is there a signal intensity increase in the dentate nucleus and the globus pallidus?
    Jaulent P; Hannoun S; Kocevar G; Rollot F; Durand-Dubief F; Vukusic S; Brisset JC; Sappey-Marinier D; Cotton F
    Eur J Radiol; 2018 Aug; 105():204-208. PubMed ID: 30017281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent.
    Radbruch A; Weberling LD; Kieslich PJ; Eidel O; Burth S; Kickingereder P; Heiland S; Wick W; Schlemmer HP; Bendszus M
    Radiology; 2015 Jun; 275(3):783-91. PubMed ID: 25848905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linear gadolinium-based contrast agent (gadodiamide and gadopentetate dimeglumine)-induced high signal intensity on unenhanced T
    Ichikawa S; Omiya Y; Onishi H; Motosugi U
    J Magn Reson Imaging; 2019 Apr; 49(4):1046-1052. PubMed ID: 30307671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple Administrations of Gadobutrol in the Pediatric Brain: No Change in T1 Signal at MRI.
    Bhargava R; Persad ARL; Bhargava NK; Hawkes M
    Radiology; 2018 Oct; 289(1):204-209. PubMed ID: 29944079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The switch from Gd-DTPA to Gd-DOTA is not associated with decrease of the T1 signal intensity of the pallidus and dentate in a pediatric population.
    Gulino P; Bianchi A; Diciotti S; Scionti A; Sali L; Papadopulos P; Mascalchi M
    Acta Radiol; 2021 Mar; 62(3):368-376. PubMed ID: 32529894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the effect of multiple administrations of gadopentetate dimeglumine or gadoterate meglumine on brain T1-weighted hyperintensity in pediatric patients.
    Towbin AJ; Zhang B; Dillman JR
    Pediatr Radiol; 2021 Dec; 51(13):2568-2580. PubMed ID: 34286351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric Brain: Repeated Exposure to Linear Gadolinium-based Contrast Material Is Associated with Increased Signal Intensity at Unenhanced T1-weighted MR Imaging.
    Flood TF; Stence NV; Maloney JA; Mirsky DM
    Radiology; 2017 Jan; 282(1):222-228. PubMed ID: 27467467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric Brain: No Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-weighted MR Images after Consecutive Exposure to a Macrocyclic Gadolinium-based Contrast Agent.
    Radbruch A; Haase R; Kickingereder P; Bäumer P; Bickelhaupt S; Paech D; Wick W; Schlemmer HP; Seitz A; Bendszus M
    Radiology; 2017 Jun; 283(3):828-836. PubMed ID: 28273007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective cohort evaluation of the effect of multiple administrations of gadopentetate dimeglumine on brain magnetic resonance imaging T1-weighted signal.
    Towbin AJ; Zhang B; Dillman JR
    Pediatr Radiol; 2021 Mar; 51(3):457-470. PubMed ID: 33399985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
    Kasper E; Schemuth HP; Horry S; Kinner S
    Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter, randomized, controlled, single-blind comparison phase III study to determine the efficacy and safety of gadobutrol 1.0 M versus gadopentetate dimeglumine following single injection in patients referred for contrast-enhanced MRI of the body regions or extremities.
    Kuwatsuru R; Takahashi S; Umeoka S; Sugihara R; Zeng M; Huan Y; Peng W; Ma L; Guo L; Teng G; Yao W; Tozaki M; Endo M; Kaji S; Ro T; Tae Hahn S; Chul Kang B; Nishimura H; Sugawara Y; Katakami N; Breuer J; Aitoku Y
    J Magn Reson Imaging; 2015 Feb; 41(2):404-13. PubMed ID: 24692302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gadoterate Meglumine Administration in Multiple Sclerosis has no Effect on the Dentate Nucleus and the Globus Pallidus Signal Intensities.
    Hannoun S; Issa R; El Ayoubi NK; Haddad R; Baalbaki M; Yamout BI; Khoury SJ; Hourani R
    Acad Radiol; 2019 Oct; 26(10):e284-e291. PubMed ID: 30527456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility-Weighted Imaging of the Pediatric Brain after Repeat Doses of Gadolinium-Based Contrast Agent.
    Ozturk K; Nascene D
    AJNR Am J Neuroradiol; 2021 Jun; 42(6):1136-1143. PubMed ID: 33888459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.